Form D · Pharmaceuticals
SteadySleep Rx Co.
Louisville, CO · CIK 0001505346
Offering snapshot reported Nov 12, 2010 · SEC filing
- Reported sold
- $800K Offering amount: $800K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Oct 29, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 12, 2010 | Initial | $800,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-150360
Source: Form D, filed Nov 12, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bruce N. Barron | Director |
| David W. Carley | Director, Executive |
| Kenneth Cohen | Director |
| Kathryn B. Hyer | Director, Executive |
| Peter W. Letendre | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
901 Front St. Suite 201
Louisville, CO, 80027
Louisville, CO, 80027